News & Updates

In a study presented at Crohn’s and Colitis Congress 2024, infliximab and vedolizumab were found to have similar effectiveness in achiev­ing steroid-free clinical remission (SFCR) and biochemical remission (BR) at 12 months when used as first-line treatment for biologic-naïve paediatric patients with un­complicated mild-to-moderately active inflammatory bowel disease (IBD).

A multidisciplinary intervention program for type 2 diabetes (T2D) in the primary care setting subsequently reduces the incidence of dementia, as reported in a study.

Current guidelines that are being used in Singapore (SG) for predicting cardiovascular disease (CVD) must be updated to improve risk prediction accuracy. This can be done by recalibrating risk functions and employing wearable metrics that provide a huge amount of objective health data, suggests a study.

Critically ill patients with obesity see a significant rise in their body temperature following the use of dexmedetomidine (DEX) for ongoing sedation, as shown in a recent study. Furthermore, DEX duration and baseline temperature are significantly associated with fever development in these individuals.

Treatment with reteplase appears more effective than alteplase in patients with acute ischaemic stroke (AIS) who have been treated within 4.5 hours of symptom onset, according to the results of RAISE, a phase III multicentre, open-label, randomized controlled, noninferiority trial.